Prolgolimab
![Prolgolimab](/46/product/123/32/98/Artboard%202.png)
Product Description
BIOCAD
![BIOCAD](/c247619img_XL-comp247619.jpg)
-
RU
-
2015On CPHI since
Categories
BIOCAD
![BIOCAD](/c247619img_XL-comp247619.jpg)
-
RU
-
2015On CPHI since
More Products from BIOCAD (2)
-
Product Netakimab
ONetakimab – an original humanized monoclonal antibody against IL-17. Approved in Russia for plaque psoriasis. Pending approval for ankylosing spondylitis. BIOCAD will also launch an international Phase III clinical trial with the aim of approval in EU. -
Product Rituximab
Rituximab biosimilar, chimeric monoclonal antibody which specifically binds to the transmembrane antigen CD20. Indications: non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis (GPA) and microscopic polyangiitis (MPA)...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance